Alivus Life

{
  "main_header": {
    "sid": 1003513,
    "name": "Alivus Life",
    "stock_name": "Alivus Life",
    "full_name": "Alivus Life Sciences Ltd",
    "name_url": "stocks-analysis/alivus-life",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,158.90",
    "chg": 63.45,
    "chgp": "5.79%",
    "dir": 1,
    "prev_price": "1,095.45",
    "mcapval": "14,224.27 Cr",
    "mcap": "Small Cap",
    "scripcode": 543322,
    "symbol": "ALIVUS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE03Q201024",
    "curr_date": "Jul 31, 02:50 PM",
    "curr_time": "14:52 PM",
    "last_traded_at": "Jul 31, 02:50 PM IST",
    "bse_nse_vol": "2.29 lacs",
    "exc_status": "Active",
    "traded_date": "Jul 31, 2026",
    "traded_date_str": "2026 07 31",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/alivus-life-1003513-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Alivus Life Sciences Ltd Surges 7.33% to Day's High of Rs 1167.7 — Outperforms Sector by 5.26 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-hits-intraday-high-with-733-surge-on-31-jul-2026-4130331",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AlivusLifeScien_priceRelatedfactors_4130331.png",
        "date": "2026-07-31 11:46:45",
        "description": "The Sensex edged up 0.14% on 31 Jul 2026, while Alivus Life Sciences Ltd surged 7.33%, outperforming its Pharmaceuticals & Biotechnology sector by 5.26 percentage points. This sharp single-session gain stands out as a stock-specific event amid a broadly positive but modest market advance."
      },
      {
        "title": "Alivus Life Sciences Q1 FY27: Margin Excellence Overshadowed by Revenue Decline",
        "link": "https://www.marketsmojo.com/news/result-analysis/alivus-life-sciences-q1-fy27-margin-excellence-overshadowed-by-revenue-decline-4130356",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AlivusLifeScien_quaterlyResult_4130356.png",
        "date": "2026-07-31 09:53:32",
        "description": "Alivus Life Sciences Ltd., a small-cap pharmaceutical company with a market capitalisation of ₹14,115.04 crores, reported a mixed performance in Q1 FY27, with net profit climbing to ₹160.08 crores but revenue contracting quarter-on-quarter. The stock surged 4.98% on the day of this analysis, trading at ₹1,150.00, reflecting investor optimism about the company's margin expansion despite top-line headwinds."
      },
      {
        "title": "When is the next results date for Alivus Life Sciences Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-alivus-life-sciences-ltd-4119919",
        "imagepath": "",
        "date": "2026-07-24 23:17:28",
        "description": "The next results date for Alivus Life Sciences Ltd is scheduled for 30 July 2026...."
      },
      {
        "title": "Alivus Life Sciences Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alivus-life-sciences-ltd-is-rated-hold-4115047",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AlivusLifeScien_mojoScore_4115047.png",
        "date": "2026-07-22 10:11:01",
        "description": "Alivus Life Sciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 06 Jul 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Alivus Life Sciences Ltd Sees Technical Momentum Shift Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-sees-technical-momentum-shift-amid-mixed-indicator-signals-4100055",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AlivusLifeScien_technicaldot_4100055.png",
        "date": "2026-07-14 08:06:11",
        "description": "Alivus Life Sciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a slight dip in the daily price, key technical indicators such as MACD and Bollinger Bands maintain a positive outlook, while others like KST and OBV suggest caution. This nuanced technical landscape warrants a detailed analysis for investors seeking clarity on the stock’s near-term trajectory."
      },
      {
        "title": "Alivus Life Sciences Ltd Technical Momentum Shifts to Bullish Amid Strong Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-technical-momentum-shifts-to-bullish-amid-strong-returns-4097818",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AlivusLifeScien_technicaldot_4097818.png",
        "date": "2026-07-13 08:04:11",
        "description": "Alivus Life Sciences Ltd has demonstrated a notable shift in price momentum, supported by a series of bullish technical indicators across multiple timeframes. The stock’s recent upgrade from a Buy to a Hold rating reflects a nuanced view of its evolving market dynamics, with technical parameters signalling increased investor confidence amid a competitive pharmaceutical sector backdrop."
      },
      {
        "title": "Alivus Life Sciences Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alivus-life-sciences-ltd-is-rated-hold-4096918",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AlivusLifeScien_mojoScore_4096918.png",
        "date": "2026-07-11 10:10:32",
        "description": "Alivus Life Sciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 06 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Alivus Life Sciences Ltd Sees Technical Momentum Shift Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-sees-technical-momentum-shift-amid-mixed-indicator-signals-4091506",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AlivusLifeScien_technicaldot_4091506.png",
        "date": "2026-07-07 08:07:40",
        "description": "Alivus Life Sciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a slight dip in the daily price, key technical indicators present a nuanced picture, signalling both opportunities and caution for investors navigating this evolving landscape."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Alivus Life Sciences Ltd to 52-Week High of Rs 1193.3",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-hits-new-52-week-high-at-rs11933-4084960",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AlivusLifeScien_priceRelatedfactors_4084960.png",
        "date": "2026-07-02 11:09:01",
        "description": "With a decisive break above Rs 1193.3 on 2 Jul 2026, Alivus Life Sciences Ltd has reached a fresh 52-week high, propelled by a confluence of bullish technical indicators and sustained price momentum that outpaces its sector and the broader market."
      }
    ],
    "total": 318,
    "sid": "1003513",
    "stock_news_url": "https://www.marketsmojo.com/news/alivus-life-sciences-1003513"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "23-Jul-2026",
      "details": "Intimation of closure of Trading Window from 1st July 2026 to 1st August 2026 (both days inclusive) for the purpose of approval of unaudited financial results for the quarter ended 30th June 2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "23-Jul-2026",
      "details": "Enclosed please find herewith the details of Earnings Call slated for Friday July 31 2026 from 8:30 a.m. to 9:30 a.m. (IST) for your information and record.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Considering And Approving Unaudited Financial Results Of The Company For The Quarter Ended 30Th June 2026.",
      "datetime": "23-Jul-2026",
      "details": "Alivus Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2026 inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter ended 30th June 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Alivus Life Sciences Ltd has declared <strong>250%</strong> dividend, ex-date: 01 Sep 25",
          "dt": "2025-09-01",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Alivus Life Sciences Ltd Surges 7.33% to Day's High of Rs 1167.7 — Outperforms Sector by 5.26 Percentage Points

2026-07-31 11:46:45

The Sensex edged up 0.14% on 31 Jul 2026, while Alivus Life Sciences Ltd surged 7.33%, outperforming its Pharmaceuticals & Biotechnology sector by 5.26 percentage points. This sharp single-session gain stands out as a stock-specific event amid a broadly positive but modest market advance.

Read full news article

Alivus Life Sciences Q1 FY27: Margin Excellence Overshadowed by Revenue Decline

2026-07-31 09:53:32

Alivus Life Sciences Ltd., a small-cap pharmaceutical company with a market capitalisation of ₹14,115.04 crores, reported a mixed performance in Q1 FY27, with net profit climbing to ₹160.08 crores but revenue contracting quarter-on-quarter. The stock surged 4.98% on the day of this analysis, trading at ₹1,150.00, reflecting investor optimism about the company's margin expansion despite top-line headwinds.

Read full news article

When is the next results date for Alivus Life Sciences Ltd?

2026-07-24 23:17:28

The next results date for Alivus Life Sciences Ltd is scheduled for 30 July 2026....

Read full news article

Alivus Life Sciences Ltd is Rated Hold

2026-07-22 10:11:01

Alivus Life Sciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 06 Jul 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Alivus Life Sciences Ltd Sees Technical Momentum Shift Amid Mixed Indicator Signals

2026-07-14 08:06:11

Alivus Life Sciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a slight dip in the daily price, key technical indicators such as MACD and Bollinger Bands maintain a positive outlook, while others like KST and OBV suggest caution. This nuanced technical landscape warrants a detailed analysis for investors seeking clarity on the stock’s near-term trajectory.

Read full news article

Alivus Life Sciences Ltd Technical Momentum Shifts to Bullish Amid Strong Returns

2026-07-13 08:04:11

Alivus Life Sciences Ltd has demonstrated a notable shift in price momentum, supported by a series of bullish technical indicators across multiple timeframes. The stock’s recent upgrade from a Buy to a Hold rating reflects a nuanced view of its evolving market dynamics, with technical parameters signalling increased investor confidence amid a competitive pharmaceutical sector backdrop.

Read full news article

Alivus Life Sciences Ltd is Rated Hold

2026-07-11 10:10:32

Alivus Life Sciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 06 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Alivus Life Sciences Ltd Sees Technical Momentum Shift Amid Mixed Indicator Signals

2026-07-07 08:07:40

Alivus Life Sciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a slight dip in the daily price, key technical indicators present a nuanced picture, signalling both opportunities and caution for investors navigating this evolving landscape.

Read full news article

Broad-Based Technical Strength Lifts Alivus Life Sciences Ltd to 52-Week High of Rs 1193.3

2026-07-02 11:09:01

With a decisive break above Rs 1193.3 on 2 Jul 2026, Alivus Life Sciences Ltd has reached a fresh 52-week high, propelled by a confluence of bullish technical indicators and sustained price momentum that outpaces its sector and the broader market.

Read full news article

View All News